StonvexLoading…
StonvexStonvexStonvexCore line items from CNK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.12B | $3.05B | $3.07B | $2.45B |
Operating Income | $153.90M | $252.80M | $221.40M | $-265.00M |
Net Income | $138.20M | $309.70M | $188.20M | $-271.20M |
EPS (Diluted) | $1.04 | $2.06 | $1.34 | $-2.26 |
Total Assets | Not available | Not available | Not available | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $0.00 | $0.00 | $10.80M | $14.90M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 134.30M | 154.90M | 152.00M | 118.20M |